Navigation Links
Latest Sleep Disorder Technology Tested With SleepQuest
Date:9/4/2008

SAN CARLOS, Calif., Sept. 4 /PRNewswire/ -- SleepQuest has partnered with ResMed, a leading manufacturer of medical equipment for sleep-disordered breathing, to conduct clinical trials of a new wireless technology used to monitor patients with Obstructive Sleep Apnea from wherever they are sleeping. The technology is intended to more easily provide data that can be used to improve the quality of care for those requiring PAP treatment.

"We take pride in working with companies on the cutting edge of technology," said Robert Koenigsberg, President/CEO of SleepQuest. "We want to deploy that expertise on behalf of our patients."

Employing Bluetooth technology, sleep data transmits instantly from a CPAP or other medical device to SleepQuest's Sleep Care Specialists, allowing them to monitor adherence that can increase treatment efficacy. This improves patient comfort, ensures better compliance, and reduces need for office visits or in-person device adjustments.

A total of 30 SleepQuest sleep apnea patients are currently participating in the trial. These patients report that the technology is easy to use and presents no technical problems, improving patient convenience by reducing the need for office visits to download data.

ResMed selected SleepQuest to lead this initiative because of their proven disease management approach for Obstructive Sleep Apnea and industry-leading treatment compliance rate.

"Ensuring that patients properly manage their condition through nightly CPAP treatment is our main goal," said Cody Parker, Regional Office Manager "Helping ResMed develop this wireless technology will benefit our patients by making CPAP treatment more comfortable and effective."

SleepQuest has found that without continued support and encouragement, many patients stop treatment after a few weeks. Their Continuum of Care program was developed in response: a step-by-step approach to diagnose and treat sleep apnea with thorough clinical and home support. The result is a patient therapy compliance rate of approximately 90%, compared to the industry average of about 50%.

"We are always looking for ways to provide convenient treatment and follow-up care for our patients," Parker said. "Immediate data transfer allows us to serve our patients more efficiently, saving them time and money."

For more than 10 years, SleepQuest has established itself as a leader in home testing and treatment of sleep apnea. To talk to a SleepQuest representative about treating sleep disorders call 800-813-8358 or email contact@sleepquest.com.


'/>"/>
SOURCE SleepQuest
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
2. UD researchers race ahead with latest spintronics achievement
3. Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center
4. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
5. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
6. PacifiCare Capitulates to Latest Patient Revolt
7. Parks Associates Digital Health Analyst to Present Latest Research and Forecasts at ATA Show
8. Carbon nanotube measurements: latest in NIST how-to series
9. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
10. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
11. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ... host a live webcast of its Annual Meeting of Shareholders on ... The webcast can be accessed from the BD corporate website at ... 31, 2017. ... About BD BD is a global medical technology company that ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, will feature data ... napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held ... . Napabucasin is an orally-administered investigational ... STAT3. i Cancer stem cells (CSCs) possess the ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... for Clinical Ops Executives 2017 in its continued commitment to the advancement of ... makers to discuss current issues related to clinical trial planning and management. ...
(Date:1/18/2017)... ... 18, 2017 , ... Announced in December 2016, RoosterBio is ... Secretary of Commerce Penny Pritzker has announced the award of a new National ... announced the award of a new Advanced Regenerative Manufacturing Institute (ARMI). These are ...
Breaking Biology Technology:
(Date:12/15/2016)... -- ... Research and Markets has announced the addition of the "Global Military ... report forecasts the global military biometrics market to grow at a CAGR ... been prepared based on an in-depth market analysis with inputs from industry ... the coming years. The report also includes a discussion of the key ...
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , the ... of its patent portfolio, which grew to over 40 granted and pending ... , , ... filed patent entitled " System, Device, and Method Estimating Force ... enables device makers to forego costly hardware components needed to estimate the ...
Breaking Biology News(10 mins):